Keyword Index
Browse for an article via relevant keywords across our entire electronic archive
Search results for: E
Results 1 - 10 of 338 shown below
E-cadherin
W Jiao, K Miyazaki and Y Kitajima
Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo
doi:10.1038/sj.bjc.6600017
Abstract | Full article | PDF
-
J-L Ku, K-A Yoon, I-J Kim, W-H Kim, J-Y Jang, K-S Suh, S-W Kim, Y-H Park, J-H Hwang, Y-B Yoon and J-G Park
Establishment and characterisation of six human biliary tract cancer cell lines
doi:10.1038/sj.bjc.6600440
Abstract | Full article | PDF
-
J J French, J Cresswell, W K Wong, K Seymour, R M Charnley and J A Kirby
T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?
doi:10.1038/sj.bjc.6600597
Abstract | Full article | PDF
-
K B Pedersen, J M Nesland, Ø Fodstad and G M Mælandsmo
Expression of S100A4, E-cadherin,
- and
-catenin in breast cancer biopsiesdoi:10.1038/sj.bjc.6600624
Abstract | Full article | PDF
-
C G Colpaert, P B Vermeulen, I Benoy, A Soubry, F Van Roy, P van Beest, G Goovaerts, L Y Dirix, P Van Dam, S B Fox, A L Harris and E A Van Marck
Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression
doi:10.1038/sj.bjc.6600807
Abstract | Full article | PDF
-
T Nakashima, C Huang, D Liu, K Kameyama, D Masuya, S Kobayashi, M Kinoshita and H Yokomise
Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients
doi:10.1038/sj.bjc.6600955
Abstract | Full article | PDF
-
N Tanaka, T Odajima, K Ogi, T Ikeda and M Satoh
Expression of E-cadherin,
-catenin, and
-catenin in the process of lymph node metastasis in oral squamous cell carcinomadoi:10.1038/sj.bjc.6601124
Abstract | Full article | PDF
-
G Ronzitti, F Callegari, C Malaguti and G P Rossini
Selective disruption of the E-cadherin–catenin system by an algal toxin
doi:10.1038/sj.bjc.6601640
Abstract | Full article | PDF
-
M J Larriba and A Muñoz
SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications
advance online publication, 2005-03-15 00:00:00.000;
doi:10.1038/sj.bjc.6602484
Abstract | Full article | PDF
-
R Kuefer, M D Hofer, C S M Zorn, O Engel, B G Volkmer, M A Juarez-Brito, M Eggel, J E Gschwend, M A Rubin and M L Day
Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer
advance online publication, 2005-05-03 00:00:00.000;
doi:10.1038/sj.bjc.6602599
Abstract | Full article | PDF
-
N Bhagavathula, E A Kelley, M Reddy, K C Nerusu, C Leonard, K Fay, S Chakrabarty and J Varani
Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma
advance online publication, 2005-11-08 00:00:00.000;
doi:10.1038/sj.bjc.6602852
Abstract | Full article | PDF
-
A Batistatou, C D Scopa, P Ravazoula, Y Nakanishi, D Peschos, N J Agnantis, S Hirohashi and K A Charalabopoulos
Involvement of dysadherin and E-cadherin in the development of testicular tumours
doi:10.1038/sj.bjc.6602880
Abstract | Full article | PDF
-
M Lombaerts, T van Wezel, K Philippo, J W F Dierssen, R M E Zimmerman, J Oosting, R van Eijk, P H Eilers, B van de Water, C J Cornelisse and A-M Cleton-Jansen
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines
advance online publication, 2006-02-21 00:00:00.000;
doi:10.1038/sj.bjc.6602996
Abstract | Full article | PDF
-
D Krubasik, N G Iyer, W R English, A A Ahmed, M Vias, C Roskelley, J D Brenton, C Caldas and G Murphy
Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition
advance online publication, 2006-04-18 00:00:00.000;
doi:10.1038/sj.bjc.6603101
Abstract | Full article | PDF
-
M Shioiri, T Shida, K Koda, K Oda, K Seike, M Nishimura, S Takano and M Miyazaki
Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients
doi:10.1038/sj.bjc.6603193
Abstract | Full article | PDF
-
A Batistatou, D Peschos, H Tsanou, A Charalabopoulos, Y Nakanishi, S Hirohashi, N J Agnantis and K Charalabopoulos
In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin
advance online publication, 2007-04-17 00:00:00.000;
doi:10.1038/sj.bjc.6603743
Abstract | Full article | PDF
-
K L Sodek, M J Ringuette and T J Brown
MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells
advance online publication, 2007-07-03 00:00:00.000;
doi:10.1038/sj.bjc.6603863
Abstract | Full article | PDF
-
K Blechschmidt, S Sassen, B Schmalfeldt, T Schuster, H Höfler and K-F Becker
The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients
advance online publication, 2007-11-20 00:00:00.000;
doi:10.1038/sj.bjc.6604115
Abstract | Full article | PDF
-
W N Yap, P N Chang, H Y Han, D T W Lee, M T Ling, Y C Wong and Y L Yap
-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathwaysadvance online publication, 2008-11-11 00:00:00.000;
doi:10.1038/sj.bjc.6604763
Abstract | Full article | PDF
-
N Morita, H Uemura, K Tsumatani, M Cho, Y Hirao, E Okajima, N Konishi and Y Hiasa
E-cadherin and
-,
- and
-catenin expression in prostate cancers: correlation with tumour invasiondoi:10.1038/sj.bjc.6690299
-
A S Protheroe, R E Banks, M Mzimba, W H Porter, J Southgate, P N Singh, M Bosomworth, P Harnden, P H Smith, P Whelan and P J Selby
Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer
doi:10.1038/sj.bjc.6690351
-
Y Shimada, M Imamura, G Watanabe, S Uchida, H Harada, T Makino and M Kano
Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology
doi:10.1038/sj.bjc.6690499
-
B P L Wijnhoven, N J de Both, H van Dekken, H W Tilanus and W N M Dinjens
E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus
doi:10.1038/sj.bjc.6690577
-
C Huiping, J R Sigurgeirsdottir, J G Jonasson, G Eiriksdottir, J T Johannsdottir, V Egilsson and S Ingvarsson
Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer
doi:10.1038/sj.bjc.6690815
-
M Barshishat, S Polak-Charcon and B Schwartz
Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells
doi:10.1054/bjoc.1999.0899
-
Z Popov, S Gil-Diez de Medina, M-A Lefrere-Belda, A Hoznek, S Bastuji-Garin, C C Abbou, J P Thiery, F Radvanyi and D K Chopin
Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information
doi:10.1054/bjoc.2000.1233
-
S Miyamoto, H Baba, S Kuroda, K Kaibuchi, T Fukuda, Y Maehara and T Saito
Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer
doi:10.1054/bjoc.2000.1386
-
I EI-Hariry, M Pignatelli and N R Lemoine
FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines
doi:10.1054/bjoc.2001.1813
E-cadherin mutations
J Stone, S Bevan, D Cunningham, A Hill, N Rahman, J Peto, A Marossy and R S Houlston
Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer
doi:10.1038/sj.bjc.6690308
-
N Rahman, J G Stone, G Coleman, B Gusterson, S Seal, A Marossy, S R Lakhani, A Ward, A Nash, A McKinna, R A'Hern, M R Stratton and R S Houlston
Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
doi:10.1054/bjoc.1999.0965
E-selectin
C-M Liu, T-S Sheen, J-Y Ko and C-T Shun
Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer
doi:10.1038/sj.bjc.6690057
-
M Martín-Satué, C de Castellarnau and J Blanco
Overexpression of
(1,3)-fucosyltransferase VII is sufficient for the acquisition of lung colonization phenotype in human lung adenocarcinoma HAL-24Luc cellsdoi:10.1038/sj.bjc.6690482
E. tirucalli
A MacNeil, O P Sumba, M L Lutzke, A Moormann and R Rochford
Activation of the Epstein–Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli
doi:10.1038/sj.bjc.6600929
Abstract | Full article | PDF
E1B-deleted
J-L Hsieh, C-L Wu, M-D Lai, C-H Lee, C-S Tsai and A-L Shiau
Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1–5
doi:10.1038/sj.bjc.6600908
Abstract | Full article | PDF
E2F
M Mousli, R Hopfner, A-Q Abbady, D Monté, M Jeanblanc, P Oudet, B Louis and C Bronner
ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells
doi:10.1038/sj.bjc.6601068
Abstract | Full article | PDF
-
B G Le François, J A Maroun and H C Birnboim
Expression of thymidylate synthase in human cells is an early G1 event regulated by CDK4 and p16INK4A but not E2F
advance online publication, 2007-10-09 00:00:00.000;
doi:10.1038/sj.bjc.6604020
Abstract | Full article | PDF
E6
M Kuroda, T Kiyono, K Oikawa, K Yoshida and K Mukai
The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target
advance online publication, 2005-01-11 00:00:00.000;
doi:10.1038/sj.bjc.6602329
Abstract | Full article | PDF
E6 gene, polymorphism
S Andersson, M Alemi, E Rylander, A Strand, B Larsson, J Sällström and E Wilander
Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions
doi:10.1054/bjoc.2000.1247
E6 oncogene
C Kämmer, M Tommasino, S Syrjänen, H Delius, U Hebling, U Warthorst, H Pfister and I Zehbe
Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease
doi:10.1038/sj.bjc.6600024
Abstract | Full article | PDF
E6/E7 oncogenes
M
mahel, E Sobotková, J Bubeník, J
ímová, R
ák, V Ludvíková, R Hájková, J Kova
ík, F Jelínek, C Pový
il, J Marinov and V VonkaMetastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16
doi:10.1054/bjoc.2000.1615
